New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

About this update from Neonc Technologies Holdings, Inc.

[{"type":"text","content":"CALABASAS, CA AND ABU DHABI, UAE / ACCESS Newswire / August 11, 2025 / NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the official incorporation of NuroMENA Holdings Ltd. by the Abu Dhabi Global Market (ADGM). This milestone marks the fulfillment of all contingencies required to finalize the previously announced $50 million cornerstone investment from Quazar Investment into NuroMENA Holdings Ltd.","length":533,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"New To The Street","className":"","disableSlideshowImg":false,"size":{"original":{"width":1280,"height":1021,"url":"https://media.zenfs.com/en/accesswire.ca/cf9e4a1a15c1ce25a664fbf6e9204b87"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pXQBP4bTDznyLxxb_38spQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2NjtjZj13ZWJw/https://media.zenfs.com/en/accesswire.ca/cf9e4a1a15c1ce25a664fbf6e9204b87","width":960,"height":766},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/duGEom3JkYlU3nDawRAekA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTE0O2NmPXdlYnA-/https://media.zenfs.com/en/accesswire.ca/cf9e4a1a15c1ce25a664fbf6e9204b87","width":1200,"height":957}}},{"type":"text","content":"This strategic alliance will accelerate the launch of NeOnc's innovative CNS platform across the MENA region and fast-track development of its clinical programs, including NEO212 and NEO100, two advanced therapies with the potential to transform outcomes for brain cancer and other CNS conditions.","length":301,"tagName":"p"},{"type":"blockquote","items":[{"val":[{"type":"text","content":""We view this as a defining moment for NeOnc and a major validation of our global vision," said Amir Heshmatpour, Executive Chairman and President of NeOnc Technologies. "With the finalization of NuroMENA's incorporation and the support of Quazar Investment, we are now fully equipped to advance our mission of delivering life-saving therapies to a region in urgent need of innovation. This partnership not only brings capital-it brings conviction, commitment, and alignment of purpose."","length":511,"tagName":"p"}]}],"isPullQuote":false,"pullquoteImage":null,"source":"","length":511},{"type":"blockquote","items":[{"val":[{...

More updates from Neonc Technologies Holdings, Inc.